Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haralampos J Milionis

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Expert Review of Endocrinology & Metabolism|February 13, 2019
Addison's disease and hypertransaminasemiaGeorge Kalambokis, Haralampos J Milionis
Expert Opinion on Investigational Drugs|September 24, 2008
Treatment of hyperlipidaemia with fenofibrate and related fibratesTheodosios Filippatos, Haralampos J Milionis
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 17, 2004
Metabolic alkalosis in patients with renal failureHaralampos J Milionis, Moses S Elisaf
Expert Opinion on Pharmacotherapy|September 8, 2005
Therapeutic management of hyperglycaemic hyperosmolar syndromeHaralampos J Milionis, Moses S Elisaf
American Heart Journal|August 9, 2005
Reply to Al-Shaer, is atorvastatin more appropriate to use in combination with niacin than simvastatin in patients with the metabolic syndrome? (Am Heart J 2005;149:e17.)Haralampos J Milionis, Moses S Elisaf
Drug Safety|April 20, 2010
Pharmacologically-induced metabolic acidosis: a reviewGeorge Liamis, Haralampos J Milionis, Moses Elisaf
CNS Spectrums|July 16, 2008
Metabolic syndrome and Alzheimer's disease: a link to a vascular hypothesis?Haralampos J Milionis, Matilda Florentin, Sotirios Giannopoulos
The Journal of Infection|August 13, 2011
Hyponatremia in patients with infectious diseasesGeorge Liamis, Haralampos J Milionis, Moses Elisaf
Annals of Medicine|October 23, 2010
Endocrine disorders: causes of hyponatremia not to neglectGeorge Liamis, Haralampos J Milionis, Moses Elisaf
NDT Plus|May 8, 2015
A review of drug-induced hypernatraemiaGeorge Liamis, Haralampos J Milionis, Moses Elisaf
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Expert Review of Endocrinology & Metabolism|February 13, 2019
Addison's disease and hypertransaminasemiaGeorge Kalambokis, Haralampos J Milionis
Expert Opinion on Investigational Drugs|September 24, 2008
Treatment of hyperlipidaemia with fenofibrate and related fibratesTheodosios Filippatos, Haralampos J Milionis
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 17, 2004
Metabolic alkalosis in patients with renal failureHaralampos J Milionis, Moses S Elisaf
Expert Opinion on Pharmacotherapy|September 8, 2005
Therapeutic management of hyperglycaemic hyperosmolar syndromeHaralampos J Milionis, Moses S Elisaf
American Heart Journal|August 9, 2005
Reply to Al-Shaer, is atorvastatin more appropriate to use in combination with niacin than simvastatin in patients with the metabolic syndrome? (Am Heart J 2005;149:e17.)Haralampos J Milionis, Moses S Elisaf
Drug Safety|April 20, 2010
Pharmacologically-induced metabolic acidosis: a reviewGeorge Liamis, Haralampos J Milionis, Moses Elisaf
CNS Spectrums|July 16, 2008
Metabolic syndrome and Alzheimer's disease: a link to a vascular hypothesis?Haralampos J Milionis, Matilda Florentin, Sotirios Giannopoulos
The Journal of Infection|August 13, 2011
Hyponatremia in patients with infectious diseasesGeorge Liamis, Haralampos J Milionis, Moses Elisaf
Annals of Medicine|October 23, 2010
Endocrine disorders: causes of hyponatremia not to neglectGeorge Liamis, Haralampos J Milionis, Moses Elisaf
NDT Plus|May 8, 2015
A review of drug-induced hypernatraemiaGeorge Liamis, Haralampos J Milionis, Moses Elisaf
Pageof 10